跳至主要内容
临床试验/EUCTR2018-004159-19-NL
EUCTR2018-004159-19-NL进行中(未招募)1 期

se of Copeptin Measurement after Arginine Infusion for the Diagnosis of Diabetes Insipidus - the CARGOx Study - CARGOx

niversity Hospital Basel0 个研究点目标入组 152 人开始时间: 2019年10月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Age = 18 years ?
  • 2. Hypotonic polyuria / polydipsia syndrome defined as:
  • - polyuria >50ml/kg body weight/24h and polydipsia >3l /24h or known diabetes insipidus under treatment with DDAVP
  • - Urine-Osmolality <800mOsm/L
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 122
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • 1.Polyuria / polydipsia secondary to diabetes mellitus, hypercalcemia or hypokalemia
  • 2.Nephrogenic diabetes insipidus (defined as baseline copeptin level >21.4pmol/L)
  • 3.Evidence of any acute illness
  • 4.Epilepsy requiring treatment
  • 5.Uncontrolled arterial hypertension (blood pressure >160/100mmHg at baseline)
  • 6.Cardiac failure (NYHA III-IV)
  • 7.Liver cirrhosis (Child B-C)
  • 8.Uncorrected adrenal or thyroidal deficiency
  • 9.Patients refusing or unable to give written informed consent
  • 10.Pregnancy or breast feeding
  • 11.End of life care

研究者

发起方
niversity Hospital Basel

相似试验